General form of registration statement for all companies including face-amount certificate companies

Note 3 - Revenue - Disaggregation of Revenue 1 (Details)

v3.24.4
Note 3 - Revenue - Disaggregation of Revenue 1 (Details) - Pieris Pharmaceuticals, Inc. [Member] - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Total revenue $ 0 $ 19,520 $ 53 $ 41,511 $ 42,810 $ 25,902
Astra Zeneca A B [Member]            
Total revenue 0 3,909 0 8,399 8,399 9,117
Pfizer [Member]            
Total revenue 0 9,179 6 14,088 15,134 8,287
Les Laboratoires Servier And Institut De Recherches Internationales Servier [Member]            
Total revenue 0 3,951 47 3,846 4,099 5,359
Genentech [Member]            
Total revenue 0 0 0 12,697 12,697 3,139
Boston Pharmaceuticals [Member]            
Total revenue $ 0 $ 2,481 $ 0 $ 2,481 $ 2,481 $ 0